93 related articles for article (PubMed ID: 3928233)
21. Oral gold in arthritis.
Conner CS
Drug Intell Clin Pharm; 1984 Oct; 18(10):804-5. PubMed ID: 6435987
[TBL] [Abstract][Full Text] [Related]
22. Oral gold for rheumatoid arthritis.
Wright V
Br Med J (Clin Res Ed); 1984 Oct; 289(6449):858-9. PubMed ID: 6434113
[No Abstract] [Full Text] [Related]
23. beta 2 microglobulin plasma levels reflect disease activity in rheumatoid arthritis.
Crisp AJ; Coughlan RJ; Mackintosh D; Clark B; Panayi GS
J Rheumatol; 1983 Dec; 10(6):954-6. PubMed ID: 6420563
[TBL] [Abstract][Full Text] [Related]
24. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
Davis P; Landon M
J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
[No Abstract] [Full Text] [Related]
25. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.
Larsen A; Horton J; Howland C
Clin Rheumatol; 1984 Mar; 3 Suppl 1():97-104. PubMed ID: 6432419
[TBL] [Abstract][Full Text] [Related]
26. Auranofin: more than just oral gold.
Waller ES
Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845
[No Abstract] [Full Text] [Related]
27. Auranofin: bane or bonanza for the nonrheumatologist.
Kaplan H
Am J Med; 1983 Dec; 75(6A):145-51. PubMed ID: 6419598
[TBL] [Abstract][Full Text] [Related]
28. Long term auranofin treatment in rheumatoid arthritis.
Godfrey N; Lorber A
J Rheumatol; 1985 Jun; 12(3):620-2. PubMed ID: 3930723
[No Abstract] [Full Text] [Related]
29. [Auranofin].
Ferrari M; Piro MT
Recenti Prog Med; 1983 Aug; 74(8):968-70. PubMed ID: 6417742
[No Abstract] [Full Text] [Related]
30. Auranofin in rheumatoid arthritis.
Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
[No Abstract] [Full Text] [Related]
31. Overlap between non-steroidal anti-inflammatory drugs (NSAIDs) and anti-rheumatoid drugs (ARDs).
Dixon JS
Agents Actions Suppl; 1985; 17():169-75. PubMed ID: 2868630
[No Abstract] [Full Text] [Related]
32. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
Lorber A; Kunishima DH; Harralson AF; Simon TM
J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
[TBL] [Abstract][Full Text] [Related]
33. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
Goebel KM; Storck U
Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
[TBL] [Abstract][Full Text] [Related]
34. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
Bernhard GC
J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
[TBL] [Abstract][Full Text] [Related]
35. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
36. [The pharmacology of gold compounds].
Juan H
Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
[TBL] [Abstract][Full Text] [Related]
37. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
38. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
Edelman J; Davis P; Owen ET
J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
